Vice President and Executive Director Xie Xin increased his holdings of SINO BIOPHARM (01177) by 1 million shares, with an average price of approximately HK $6.41 per share.
According to the latest data from the Hong Kong Stock Exchange, Vice President and Executive Director, Xie Xin, increased his stake in China Biopharmaceuticals (01177) on December 24 by purchasing 1 million shares at a price of 6.4068 Hong Kong dollars per share, for a total amount of 6.4068 million Hong Kong dollars.
The latest information from the Hong Kong Stock Exchange shows that on December 24, Vice President and Executive Director Xie Xin increased his holding of 1 million shares of SINO BIOPHARM (01177) at a price of 6.4068 Hong Kong dollars per share, with a total amount of 6.4068 million Hong Kong dollars. The latest number of shares held after the increase is approximately 361 million shares, with the latest shareholding ratio being 1.92%.
Related Articles
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
Bidding for Warner Bros. (WBD.US) enters a critical period, while Paramount Skydance (PSKY.US) speeds up the antitrust review process.
US Stock Market Move | Multiple departments issued letters to support the new consumption and financial consumption driving LexinFintech Holdings Ltd. Sponsored ADR Class A (LX.US) to rise by 6.04%.
Industry's First Rider Family Hospitalization Protection Implemented Meituan Upgrades Major Illness Care Plan Covering Over One Million Rider Families
